Parameter
| Biomarker | PD-L1 (Immune cells) | Full name | Programmed Death-Ligand 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis |
| Disease | TGCT | Disease Subtypes | / | ||
| Organ | Testis | Test Sample / Technology Platform | Tumor tissue (immunohistochemistry) | ||
| Pathobiological Mechanisms | High expression is associated with better prognosis, reflecting an active immune microenvironment. | ||||
| Clinical Availability Status | Stage of research | ||||
| Notes and Dynamics | Associated with lower stage and no lymph node metastasis; or a potential biomarker for immunotherapy. | ||||